Stereotactic Surgery Devices Market Research Report by Geographical Analysis and Forecast to 2023

Stereotactic surgery is a minimally invasive technique to perform actions such as biopsy, ablation, lesion, stimulation, injection, radiosurgery, and implantation. Stereotactic surgery devices include radio frequency generator, stereotactic frames, and image-based planning software that are customized for these types of surgeries. With a 3D coordinate system, the stereotactic surgery helps the surgeons in detecting the exact location to perform the procedure. Owing to its apparent benefits and rapidly improving healthcare infrastructure across the developed as well as developing nations, the demand in the global stereotactic surgery devices is expected to increase at a healthy CAGR during the forecast period of 2015 to 2023.

This report on the global market for stereotactic surgery devices has been created to serve as a credible business document for the audiences such as the manufacturers of stereotactic surgery devices, traders and distributors, research and consulting companies, hospitals and medical schools, and governing bodies. The report includes an analysis of all the factors that may influence the demand for these devices until 2023. It also contains profiles of a number of key vendors currently operating in the global stereotactic surgery devices market, estimating their market share and overviewing their product portfolio and latest strategic developments.

This report gives readers a comprehensive overview of the Stereotactic Surgery Devices Market:
http://www.transparencymarketresearch.com/stereotactic-surgery-devices-market.html

Based on equipment type, the global stereotactic surgery devices market can be segmented into the gamma knife, proton beam, and line accelerator (LINAC) machines. Application-wise, the market can be segmented into brain tumor treatment, Parkinson’s disease, arteriovenous malformations treatment, Epilepsy, and others including trigeminal neuralgia. Geographically, the report studies the potential of the regions such as North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America.

The growing preference of surgeons across the world for minimally invasive surgery is the primary driver of this market, as it provides several benefits to the patients such as quick recovery and mortality and morbidity. In addition to that, the prevalence of arteriovenous malformations, Parkinson’s disease, and epilepsy is promoting the adoption of stereotactic surgery for neurosurgeries. This factor is also expected to increment the demand for these devices significantly during the forecast period. Rising geriatric population across the world, diseases caused by changed lifestyle such as diabetes and obesity, increasing demand for enhanced drugs, and growing awareness among the patients are some of the other factors favoring the growth of the global stereotactic surgeries devices.

Get accurate market forecast and analysis on the Stereotactic Surgery Devices Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4066

Parkinson’s disease currently serves the maximum demand in this market as far as disease type segment is concerned, which is a reflection of increasing preference of stereotactic surgeries over traditional levodopa therapy, which often left to long term complications into the patients.

With robust healthcare facilities and high adoption rate of new technology, countries such as the U.S. and Canada make North America the most lucrative region for the players in this market. However, Asia Pacific is projected to increment the demand for stereotactic surgery devices at most prominent rate during the forecast period owing to improving healthcare infrastructure in several emerging economies such as Japan, India, China, Malaysia, and South Korea.

The global stereotactic surgery devices market exhibits stiff competition between the leading companies such as Alliance Oncology, Micromar, adeor Medical AG, Monteris Medical, Elekta AB., and Inomed. Development of new products with reduced planning time and enhanced clinical outcomes is the primary strategy adopted by these players to gain ground over their competitors.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.